From October 1, 2022 to December 30, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 660,400 shares, representing 0.06% for CNY 19.99 million under the buyback announced on October 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.55 CNY | -1.76% | -3.98% | -27.99% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.99% | 3.02B | |
-2.98% | 89.49B | |
+2.50% | 40.67B | |
-12.01% | 33.15B | |
+62.74% | 26.45B | |
-19.79% | 14.69B | |
-8.58% | 12.89B | |
-12.34% | 11.54B | |
-43.92% | 11.34B | |
+4.27% | 8.84B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.